{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T19:51:56Z","timestamp":1789761116222,"version":"4.0.1"},"reference-count":30,"publisher":"Galenos Yayinevi","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tjh"],"DOI":"10.4274\/tjh.galenos.2025.2025.0174","type":"journal-article","created":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T05:50:16Z","timestamp":1756878616000},"source":"Crossref","is-referenced-by-count":1,"title":["Prognostic Significance of Paraproteinemia in Marginal Zone Lymphoma"],"prefix":"10.4274","author":[{"given":"Burak","family":"Karakaya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boran","family":"Yavuz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatih","family":"Demirkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2811","published-online":{"date-parts":[[2026,2,20]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/bjh.19064","article-title":"Guideline for the diagnosis and management of marginal zone lymphomas: a British Society of Haematology Guideline","volume":"204","author":"Walewska","year":"2024","unstructured":"1. Walewska R, Eyre TA, Barrington S, Brady J, Fields P, Iyengar S, Joshi A, Menne T, Parry-Jones N, Walter H, Wotherspoon A, Linton K; BSH Committee. Guideline for the diagnosis and management of marginal zone lymphomas: a British Society of Haematology Guideline. Br J Haematol. 2024;204:86-107.","journal-title":"Br J Haematol"},{"key":"ref1","unstructured":"2. Swerdlow S, Campo E, Harris N, Jaffe E, Pileri S, Stein H, Thiele J. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (Revised 4th Edition). Lyon, IARC, 2017."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1111\/bjh.19273","article-title":"The management of newly diagnosed large B-cell lymphoma: a British Society for Haematology Guideline","volume":"204","author":"Fox","year":"2024","unstructured":"3. Fox CP, Chaganti S, McIlroy G, Barrington SF, Burton C, Cwynarski K, Eyre TA, Illidge T, Kalakonda N, Kuhnl A, McKay P, Davies AJ. The management of newly diagnosed large B-cell lymphoma: a British Society for Haematology Guideline. Br J Haematol. 2024;204:1178-1192.","journal-title":"Br J Haematol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.annonc.2020.11.008","article-title":"Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"32","author":"Dreyling","year":"2021","unstructured":"4. Dreyling M, Ghielmini M, Rule S, Salles G, Ladetto M, Tonino SH, Herfarth K, Seymour JF, Jerkeman M; ESMO Guidelines Committee. Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2021;32:298-308.","journal-title":"Ann Oncol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1056\/NEJMra2102568","article-title":"Marginal-zone lymphomas","volume":"386","author":"Rossi","year":"2022","unstructured":"5. Rossi D, Bertoni F, Zucca E. Marginal-zone lymphomas. N Engl J Med. 2022;386:568-581.","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1200\/JCO.2010.32.7577","article-title":"Transformation of indolent B-cell lymphomas","volume":"29","author":"Montoto","year":"2011","unstructured":"6. Montoto S, Fitzgibbon J. Transformation of indolent B-cell lymphomas. J Clin Oncol. 2011;29:1827-1834.","journal-title":"J Clin Oncol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.annonc.2019.10.010","article-title":"Marginal zone lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"31","author":"Zucca","year":"2020","unstructured":"7. Zucca E, Arcaini L, Buske C, Johnson PW, Ponzoni M, Raderer M, Ricardi U, Salar A, Stamatopoulos K, Thieblemont C, Wotherspoon A, Ladetto M; ESMO Guidelines Committee. Marginal zone lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2020;31:17-29.","journal-title":"Ann Oncol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1111\/bjh.16975","article-title":"Monoclonal gammopathy and serum immunoglobulin levels as prognostic factors in chronic lymphocytic leukaemia","volume":"190","author":"Corbingi","year":"2020","unstructured":"8. Corbingi A, Innocenti I, Tomasso A, Pasquale R, Visentin A, Varettoni M, Flospergher E, Autore F, Morelli F, Trentin L, Reda G, Efremov DG, Laurenti L. Monoclonal gammopathy and serum immunoglobulin levels as prognostic factors in chronic lymphocytic leukaemia. Br J Haematol. 2020;190:901-908.","journal-title":"Br J Haematol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"4440","DOI":"10.3390\/cancers15184440","article-title":"Serum paraprotein is associated with adverse prognostic factors and outcome, across different subtypes of mature B-cell malignancies-a systematic review","volume":"15","author":"Cox","year":"2023","unstructured":"9. Cox MC, Esposito F, Postorino M, Venditti A, Di Napoli A. Serum paraprotein is associated with adverse prognostic factors and outcome, across different subtypes of mature B-cell malignancies-a systematic review. Cancers (Basel). 2023;15:4440.","journal-title":"Cancers (Basel)"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1038\/s41375-022-01706-x","article-title":"IgM-secreting diffuse large B-cell lymphoma: results of a multicentre clinicopathological and molecular study","volume":"36","author":"Cox","year":"2022","unstructured":"10. Cox MC, Marcheselli L, Scafetta G, Visco C, Hohaus S, Annibali O, Musuraca G, Fabbri A, Cantonetti M, Pelliccia S, Papotti R, Petrucci L, Tani M, Battistini R, Arcari A, Luminari S, Lopez G, Alma E, Pupo L, Carli G, Marchesi F, Re F, Scarpino S, D'amore ESG, Larocca LM, Bianchi A, Pepe G, Natalino F, Anticoli-Borza P, Cenfra N, Andriani A, Abruzzese E, Tesei C, Leoncini L, Asioli S, Ruco L, Di Napoli A. IgM-secreting diffuse large B-cell lymphoma: results of a multicentre clinicopathological and molecular study. Leukemia. 2022;36:2719-2723.","journal-title":"Leukemia"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1111\/bjh.17138","article-title":"Baseline correlations and prognostic impact of serum monoclonal proteins in follicular lymphoma","volume":"193","author":"Mozas","year":"2021","unstructured":"11. Mozas P, Rivero A, Rivas-Delgado A, Fabregat A, Pi\u00f1eyroa JA, Correa JG, Nadeu F, Oliver A, Bataller A, Gin\u00e9 E, Delgado J, Villamor N, Cibeira MT, Fern\u00e1ndez de Larrea C, Rosi\u00f1ol L, Campo E, Ar\u00f3stegui JI, Blad\u00e9 J, Magnano L, L\u00f3pez-Guillermo A. Baseline correlations and prognostic impact of serum monoclonal proteins in follicular lymphoma. Br J Haematol. 2021;193:299-306.","journal-title":"Br J Haematol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1182\/blood.V95.6.1950","article-title":"Non-MALT marginal zone B-cell lymphomas: a description of clinical presentation and outcome in 124 patients","volume":"95","author":"Berger","year":"2000","unstructured":"12. Berger F, Felman P, Thieblemont C, Pradier T, Baseggio L, Bryon PA, Salles G, Callet-Bauchu E, Coiffier B. Non-MALT marginal zone B-cell lymphomas: a description of clinical presentation and outcome in 124 patients. Blood. 2000;95:1950-1956.","journal-title":"Blood"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13. Traverse-Glehen A, Felman P, Callet-Bauchu E, Gazzo S, Baseggio L, Bryon PA, Thieblemont C, Coiffier B, Salles G, Berger F. A clinicopathological study of nodal marginal zone B-cell lymphoma. A report on 21 cases. Histopathology. 2006;48:162-173.","DOI":"10.1111\/j.1365-2559.2005.02309.x"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1111\/bjh.18000","article-title":"Prognostic significance of serum immunoglobulin paraprotein in mucosa-associated lymphoid tissue (MALT) lymphoma","volume":"196","author":"Ren","year":"2022","unstructured":"14. Ren YM, Shang CY, Liang JH, Yin H, Xia Y, Wu JZ, Wang L, Jian-Yong L, Li Y, Xu W. Prognostic significance of serum immunoglobulin paraprotein in mucosa-associated lymphoid tissue (MALT) lymphoma. Br J Haematol. 2022;196:1353-1361.","journal-title":"Br J Haematol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"7179","DOI":"10.1158\/1078-0432.CCR-04-0803","article-title":"Monoclonal immunoglobulin production is a frequent event in patients with mucosa-associated lymphoid tissue lymphoma","volume":"10","author":"W\u00f6hrer","year":"2004","unstructured":"15. W\u00f6hrer S, Streubel B, Bartsch R, Chott A, Raderer M. Monoclonal immunoglobulin production is a frequent event in patients with mucosa-associated lymphoid tissue lymphoma. Clin Cancer Res. 2004;10:7179-7181.","journal-title":"Clin Cancer Res"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"5038","DOI":"10.1182\/bloodadvances.2023010133","article-title":"Impact of monoclonal protein at diagnosis on outcomes in marginal zone lymphoma: a multicenter cohort study","volume":"7","author":"Epperla","year":"2023","unstructured":"16. Epperla N, Zhao Q, Karmali R, Torka P, Shea L, Oh TS, Anampa-Guzm\u00e1n A, Reves H, Tavakkoli M, Greenwell IB, Hansinger E, Umyarova E, Annunzio K, Sawalha Y, Christian B, Thomas C, Barta SK, Geethakumari PR, Bartlett NL, Grover NS, Olszewski AJ. Impact of monoclonal protein at diagnosis on outcomes in marginal zone lymphoma: a multicenter cohort study. Blood Adv. 2023;7:5038-5046.","journal-title":"Blood Adv"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3816\/CLM.2002.n.010","article-title":"Treatment of splenic marginal zone B-cell lymphoma: an analysis of 81 patients","volume":"3","author":"Thieblemont","year":"2002","unstructured":"17. Thieblemont C, Felman P, Berger F, Dumontet C, Arnaud P, Hequet O, Arcache J, Callet-Bauchu E, Salles G, Coiffier B. Treatment of splenic marginal zone B-cell lymphoma: an analysis of 81 patients. Clin Lymphoma. 2002;3:41-47.","journal-title":"Clin Lymphoma"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/j.1349-7006.2006.00345.x","article-title":"Clinical implications of nodal marginal zone B-cell lymphoma among Japanese: study of 65 cases","volume":"98","author":"Kojima","year":"2007","unstructured":"18. Kojima M, Inagaki H, Motoori T, Itoh H, Shimizu K, Tamaki Y, Murase T, Nakamura S. Clinical implications of nodal marginal zone B-cell lymphoma among Japanese: study of 65 cases. Cancer Sci. 2007;98:44-49.","journal-title":"Cancer Sci"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/j.1365-2141.2006.06437.x","article-title":"Primary nodal marginal zone B-cell lymphoma: clinical features and prognostic assessment of a rare disease","volume":"136","author":"Arcaini","year":"2006","unstructured":"19. Arcaini L, Paulli M, Burcheri S, Rossi A, Spina M, Passamonti F, Lucioni M, Motta T, Canzonieri V, Montanari M, Bonoldi E, Gallamini A, Uziel L, Crugnola M, Ramponi A, Montanari F, Pascutto C, Morra E, Lazzarino M; Intergruppo Italiano Linfomi. Primary nodal marginal zone B-cell lymphoma: clinical features and prognostic assessment of a rare disease. Br J Haematol. 2006;136:301-304.","journal-title":"Br J Haematol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1002\/ajh.20157","article-title":"Monoclonal gammopathy in extranodal marginal zone lymphoma (ENMZL) correlates with advanced disease and bone marrow involvement","volume":"77","author":"Asatiani","year":"2004","unstructured":"20. Asatiani E, Cohen P, Ozdemirli M, Kessler CM, Mavromatis B, Cheson BD. Monoclonal gammopathy in extranodal marginal zone lymphoma (ENMZL) correlates with advanced disease and bone marrow involvement. Am J Hematol. 2004;77:144-146.","journal-title":"Am J Hematol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"102592","DOI":"10.1016\/j.eclinm.2024.102592","article-title":"Marginal zone lymphoma international prognostic index: a unifying prognostic index for marginal zone lymphomas requiring systemic treatment","volume":"72","author":"Arcaini","year":"2024","unstructured":"21. Arcaini L, Bommier C, Alderuccio JP, Merli M, Fabbri N, Nizzoli ME, Maurer MJ, Tarantino V, Ferrero S, Rattotti S, Talami A, Murru R, Khurana A, Mwangi R, Deodato M, Cencini E, Re F, Visco C, Feldman AL, Link BK, Delamain MT, Spina M, Annibali O, Pulsoni A, Ferreri AJM, Stelitano CC, Pennese E, Habermann TM, Marcheselli L, Han S, Reis IM, Paulli M, Lossos IS, Cerhan JR, Luminari S. Marginal zone lymphoma international prognostic index: a unifying prognostic index for marginal zone lymphomas requiring systemic treatment. EClinicalMedicine. 2024;72:102592.","journal-title":"EClinicalMedicine"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1182\/blood-2017-03-771915","article-title":"A MALT lymphoma prognostic index","volume":"130","author":"Thieblemont","year":"2017","unstructured":"22. Thieblemont C, Cascione L, Conconi A, Kiesewetter B, Raderer M, Gaidano G, Martelli M, Laszlo D, Coiffier B, Lopez Guillermo A, Torri V, Cavalli F, Johnson PW, Zucca E. A MALT lymphoma prognostic index. Blood. 2017;130:1409-1417.","journal-title":"Blood"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"4643","DOI":"10.1182\/blood-2005-11-4659","article-title":"Splenic marginal zone lymphoma: a prognostic model for clinical use","volume":"107","author":"Arcaini","year":"2006","unstructured":"23. Arcaini L, Lazzarino M, Colombo N, Burcheri S, Boveri E, Paulli M, Morra E, Gambacorta M, Cortelazzo S, Tucci A, Ungari M, Ambrosetti A, Menestrina F, Orsucci L, Novero D, Pulsoni A, Frezzato M, Gaidano G, Vallisa D, Minardi V, Tripodo C, Callea V, Baldini L, Merli F, Federico M, Franco V, Iannitto E; Integruppo Italiano Linfomi. Splenic marginal zone lymphoma: a prognostic model for clinical use. Blood. 2006;107:4643-4649.","journal-title":"Blood"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1093\/annonc\/mdx097","article-title":"International Working Group consensus response evaluation criteria in lymphoma (RECIL 2017)","volume":"28","author":"Younes","year":"2017","unstructured":"24. Younes A, Hilden P, Coiffier B, Hagenbeek A, Salles G, Wilson W, Seymour JF, Kelly K, Gribben J, Pfreunschuh M, Morschhauser F, Schoder H, Zelenetz AD, Rademaker J, Advani R, Valente N, Fortpied C, Witzig TE, Sehn LH, Engert A, Fisher RI, Zinzani PL, Federico M, Hutchings M, Bollard C, Trneny M, Elsayed YA, Tobinai K, Abramson JS, Fowler N, Goy A, Smith M, Ansell S, Kuruvilla J, Dreyling M, Thieblemont C, Little RF, Aurer I, Van Oers MHJ, Takeshita K, Gopal A, Rule S, de Vos S, Kloos I, Kaminski MS, Meignan M, Schwartz LH, Leonard JP, Schuster SJ, Seshan VE. International Working Group consensus response evaluation criteria in lymphoma (RECIL 2017). Ann Oncol. 2017;28:1436-1447.","journal-title":"Ann Oncol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/j.1365-2141.2006.06437.x","article-title":"Primary nodal marginal zone B-cell lymphoma: clinical features and prognostic assessment of a rare disease","volume":"136","author":"Arcaini","year":"2007","unstructured":"25. Arcaini L, Paulli M, Burcheri S, Rossi A, Spina M, Passamonti F, Lucioni M, Motta T, Canzonieri V, Montanari M, Bonoldi E, Gallamini A, Uziel L, Crugnola M, Ramponi A, Montanari F, Pascutto C, Morra E, Lazzarino M; Intergruppo Italiano Linfomi. Primary nodal marginal zone B-cell lymphoma: clinical features and prognostic assessment of a rare disease. Br J Haematol. 2007;136:301-304.","journal-title":"Br J Haematol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.3324\/haematol.2012.083386","article-title":"A systematic review","volume":"98","author":"van den Brand","year":"2013","unstructured":"26. van den Brand M, van Krieken JH. Recognizing nodal marginal zone lymphoma: recent advances and pitfalls. A systematic review. Haematologica. 2013;98:1003-1013.","journal-title":"Haematologica"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/bjh.14735","article-title":"Prognostic significance of serum immunoglobulin paraprotein in patients with diffuse large B cell lymphoma","volume":"182","author":"Li","year":"2018","unstructured":"27. Li Y, Wang L, Zhu HY, Liang JH, Wu W, Wu JZ, Xia Y, Fan L, Li JY, Xu W. Prognostic significance of serum immunoglobulin paraprotein in patients with diffuse large B cell lymphoma. Br J Haematol. 2018;182:131-134.","journal-title":"Br J Haematol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1002\/ajh.25446","article-title":"Short survival and frequent transformation in extranodal marginal zone lymphoma with multiple mucosal sites presentation","volume":"94","author":"Alderuccio","year":"2019","unstructured":"28. Alderuccio JP, Zhao W, Desai A, Ramdial J, Gallastegui N, Kimble E, de la Fuente MI, Husnain M, Rosenblatt JD, Alencar AJ, Schatz JH, Moskowitz CH, Chapman JR, Vega F, Reis IM, Lossos IS. Short survival and frequent transformation in extranodal marginal zone lymphoma with multiple mucosal sites presentation. Am J Hematol. 2019;94:585-596.","journal-title":"Am J Hematol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1634\/theoncologist.11-3-285","article-title":"Nongastric marginal-zone B-cell MALT lymphoma: prognostic value of disease dissemination","volume":"11","author":"Arcaini","year":"2006","unstructured":"29. Arcaini L, Burcheri S, Rossi A, Passamonti F, Paulli M, Boveri E, Brusamolino E, Orlandi E, Molteni A, Pulsoni A, Cox MC, Orsucci L, Fabbri A, Frezzato M, Voso MT, Zaja F, Montanari F, Pascutto C, Morra E, Cortelazzo S, Lazzarino M. Nongastric marginal-zone B-cell MALT lymphoma: prognostic value of disease dissemination. Oncologist. 2006;11:285-291.","journal-title":"Oncologist"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.3109\/10428194.2013.767456","article-title":"Immunoglobulin heavy chain\/light chain pair measurement is associated with survival in diffuse large B-cell lymphoma","volume":"54","author":"Jardin","year":"2013","unstructured":"30. Jardin F, Delfau-Larue MH, Molina TJ, Copie-Bergman C, Bri\u00e8re J, Petrella T, Canioni D, Fabiani B, Jais JP, Figeac M, Leroy K, Mareschal S, Salles GA, Coiffier B, Delarue R, Peyrade F, Bosly A, Andr\u00e9 M, Ketterer N, Haioun C, Tilly H. Immunoglobulin heavy chain\/light chain pair measurement is associated with survival in diffuse large B-cell lymphoma. Leuk Lymphoma. 2013;54:1898-1907.","journal-title":"Leuk Lymphoma"}],"container-title":["Turkish Journal of Hematology"],"original-title":[],"deposited":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T07:51:03Z","timestamp":1771833063000},"score":1,"resource":{"primary":{"URL":"https:\/\/jag.journalagent.com\/z4\/download_fulltext.asp?pdir=tjh&plng=eng&un=TJH-90868"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,20]]},"references-count":30,"URL":"https:\/\/doi.org\/10.4274\/tjh.galenos.2025.2025.0174","relation":{},"ISSN":["1300-7777","1308-5263"],"issn-type":[{"value":"1300-7777","type":"print"},{"value":"1308-5263","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,20]]}}}